# Norepinephrine Bitartrate

NDC: 71839-143
Generic name: norepinephrine bitartrate
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20231230

FDA application: ANDA217575

## Active ingredients

- NOREPINEPHRINE BITARTRATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-143"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-143
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c42d425a-094e-4390-b4f9-4bb4b0fbc7d0